Leukocytes and the risk of ischemic diseases

JAMA
|May 1, 1987
PubMed

Insights

High white blood cell (WBC) counts, even within the normal range, significantly increase the risk of heart attack and stroke. This finding suggests WBC count is an important, underutilized predictor of atherosclerotic disease.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Epidemiology

Background:

  • Current atherosclerotic risk prediction models are incomplete.
  • White blood cell (WBC) count is a potential, under-recognized predictor of cardiovascular events.
  • Elevated WBC counts correlate with increased risk of myocardial infarction and stroke.

Purpose of the Study:

  • To investigate the association between WBC count and atherosclerotic disease risk.
  • To explore the potential of WBC count as a predictive factor for cardiovascular events.

Main Methods:

  • Epidemiological analysis of WBC counts in relation to myocardial infarction and stroke risk.
  • Examination of the correlation between high-normal WBC counts and cardiovascular event risk.
  • Consideration of neutrophil count as a specific WBC type associated with risk.

Main Results:

  • Individuals with high-normal WBC counts (>9000/microL) have approximately four times the risk of acute myocardial infarction compared to those with low-normal counts (<6000/microL).
  • Tobacco smoking explains only 50%-65% of this excess risk, indicating other factors are involved.
  • High WBC count also predicts increased risk of reinfarction and in-hospital mortality.

Conclusions:

  • WBC count, particularly neutrophil count, is a significant predictor of atherosclerotic disease risk.
  • WBCs influence blood rheology and contribute to endothelial injury, explaining their predictive value.
  • Future research may refine risk prediction by incorporating WBC activation markers.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Structure and Function of Leukocytes01:21

Structure and Function of Leukocytes

An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...